Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/10/1993 | EP0530311A1 The use of phenylpropanolamine as a mucus secretagogue in the upper airways |
03/10/1993 | EP0530286A1 Process for the stereoselective preparation of phenylisoserin derivatives. |
03/10/1993 | EP0530285A1 Process for the enantioselective preparation of phenylisoserin derivatives. |
03/10/1993 | EP0530268A1 Process for the preparation of 7-alpha-alkoxycephem derivatives. |
03/10/1993 | EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof |
03/10/1993 | EP0530242A1 Compounds |
03/10/1993 | EP0530207A1 Imidazopyridine paf antagonists |
03/10/1993 | EP0530198A1 Heterocyclic compounds as aldose reductase inhibitors |
03/10/1993 | EP0525033A4 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
03/10/1993 | EP0525002A4 2(5h)-furanones substituted in the 3 position, as ca?2+ channel antagonists and anti-inflammatory agents |
03/10/1993 | EP0524979A4 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents |
03/10/1993 | EP0521871A4 Alternative enzyme substrates as deodorants |
03/10/1993 | EP0519983A4 Use of ketorolac for treatment of periodontal disease |
03/10/1993 | EP0514437A4 Branched alkyl esters of 4-bis (chloroethyl) aminophenyl-alkyl carboxylic acids for treatment of primary and metastatic tumors of the lymphatic system, and of cancers of the breast and ovaries |
03/10/1993 | EP0455648B1 Dosage form for administering calcium antagonist |
03/10/1993 | EP0447414B1 Use of minoxidil for wound healing |
03/10/1993 | EP0439570B1 A novel use of beta-receptor blocking agents for treatment of menieres' disease |
03/10/1993 | EP0365519B1 Topical prodrugs for treatment of acne and skin diseases |
03/10/1993 | EP0364490B1 A method for detecting a retinoblastoma gene defect in tumors using a retinoblastoma gene probe |
03/10/1993 | EP0312581B1 Pharmaceutical sustained release matrix and process |
03/10/1993 | CN1069741A Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
03/10/1993 | CN1069733A 6-Oxo-azepinoindole and process for producing same and intermediate and application as pharmaceutical |
03/10/1993 | CN1069732A 1,7-Condensed 2-(piperazinealkyl)-indole derivatives and process for preparing same and intermediate and pharmaceutical containing same |
03/10/1993 | CN1069731A Dibenz |b,f¨ |1,4¨ oxazepin-11(10H)-ones for multidrug resistance reversing agents |
03/10/1993 | CN1069727A Therapeutic amides |
03/10/1993 | CN1069726A Medicaments |
03/10/1993 | CN1069724A New purpose of sinapine for preventing radiation injury to animals and plants |
03/10/1993 | CN1069722A 4-Demethoxy-4-amino daunomycinone and process for preparing same |
03/10/1993 | CN1069651A Production method of quick effect wound-healing |
03/10/1993 | CA2077732A1 Heterocyclic derivatives |
03/10/1993 | CA2077638A1 N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n- alkynylheteroarylmacrolides having immunosuppressive activity |
03/10/1993 | CA2077611A1 Antibiotic ll-e19020 zeta and ll-e19020 eta |
03/10/1993 | CA2077610A1 Recovery process for antibiotics ll-e19020 alpha and beta |
03/10/1993 | CA2077597A1 Antibiotic ll-e19020 alpha 1 |
03/10/1993 | CA2077583A1 Antibiotic ll-e19020 gamma |
03/10/1993 | CA2077331A1 O-heteroaryl, o-alkylheteroaryl, o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosuppressive activity |
03/10/1993 | CA2074419A1 1,4-dihydropyridines with paf-antagonistic activity |
03/10/1993 | CA2050948A1 5-benzyl substituted-benzimidazo-line-2-thion derivatives and a process for preparing the same |
03/09/1993 | US5192808 Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease) |
03/09/1993 | US5192807 Siderophores as antiparasitic agents |
03/09/1993 | US5192806 Thromboxane A2 antagonist |
03/09/1993 | US5192805 Use of acetyl l-carnitine in the therapeutic treatment of coma |
03/09/1993 | US5192799 Coumaran group containing amine compounds and their acid addition salts and quaternary ammonium salts and the use thereof as anti arrhythmic agents and as psychotropic agents |
03/09/1993 | US5192797 Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application |
03/09/1993 | US5192795 Cognition activators |
03/09/1993 | US5192790 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis |
03/09/1993 | US5192788 Porphyrin antiviral compositions |
03/09/1993 | US5192785 Sulfamates as antiglaucoma agents |
03/09/1993 | US5192784 Physical and chemical stability |
03/09/1993 | US5192780 Methods using antiallergics and antihistamines |
03/09/1993 | US5192775 New aminomethylpiperidine compounds |
03/09/1993 | US5192773 Immunosuppressive compounds |
03/09/1993 | US5192772 Therapeutic agents |
03/09/1993 | US5192771 (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents |
03/09/1993 | US5192770 Serotonergic alpha-oxoacetamides |
03/09/1993 | US5192765 Smooth muscle, bowel, bladder and airway diseases |
03/09/1993 | US5192763 Antiischemic agents, anticonvulsants |
03/09/1993 | US5192762 Use of bridged tricyclic amine derivatives as anti-ischemic agents |
03/09/1993 | US5192761 1,2,4-triazolidine-3,5-diones and 1,3,5-triazine-2,4(1-H,3H)-diones, pharmaceutical compositions |
03/09/1993 | US5192760 3-carbalkoxyamino-5-(alpha-aminopropionyl)-5H-dibenz[b,f]azepines and method for their making |
03/09/1993 | US5192759 Derivatives of 1,2,3,4-tetrahydronaphtylamine endowed with nootropic activity and pharmaceutical compositions containing same |
03/09/1993 | US5192756 Aminosterol antibiotic |
03/09/1993 | US5192754 Treatment with steroids |
03/09/1993 | US5192753 Anti-rheumatoid arthritic drugs in the treatment of dementia |
03/09/1993 | US5192752 Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
03/09/1993 | US5192751 Administering a decahydroisoquinoline derivative |
03/09/1993 | US5192750 Using N-acetylglucosamine for treatment of allergies |
03/09/1993 | US5192740 Compositions and methods for improving cold tolerance in animals and humans |
03/09/1993 | US5192671 Fermentation with Saccharopolyspora |
03/09/1993 | US5192664 Parathyroid hypertensive factor, antibodies and uses thereof |
03/09/1993 | US5192577 Nutritional composition and a process for its production |
03/09/1993 | US5192551 Neutral glycolipid as an adsorbent for enteric viral pathogens |
03/09/1993 | US5192544 Cosmetic or pharmaceutical composition for topical application containing at least one retinoid derivative and at least one pyrimidine derivative, its use as a medicinal product and corresponding treatment process |
03/09/1993 | US5192535 Ophthalmic suspensions |
03/09/1993 | US5192527 Method of reversing local anesthesia and reagent system therefor |
03/09/1993 | US5192525 High affinity tamoxifen derivatives and uses thereof |
03/09/1993 | US5192524 Captopril as a cancer chemopreventive agent |
03/09/1993 | US5192357 Acrylate fungicides |
03/09/1993 | CA1314290C Hydroxamic acids of 7-oxabicycloheptane substituted ethers |
03/09/1993 | CA1314287C Nitrogen-containing cycloalphatic compounds having an amino acid radical and a pyridine radical |
03/09/1993 | CA1314286C Process for the preparation of eburnamenine derivatives |
03/09/1993 | CA1314285C Pseudo-primycin complexes, components and acid addition salts thereof as well as a process for the preparation of same |
03/09/1993 | CA1314283C Pyrazine diazohydroxide compounds and methods for their production and use |
03/09/1993 | CA1314255C Antibiotic reuterin |
03/09/1993 | CA1314233C Calcium supplements |
03/09/1993 | CA1314232C Amino acid composition for parenteral nutritional support |
03/09/1993 | CA1314231C Ifosphamide lyophilisate and process for its preparation |
03/09/1993 | CA1314230C Mixtures for treating hypercholesterolemia |
03/09/1993 | CA1314229C Treatment of lipoprotein disorders associated with cholesterol metabolism |
03/09/1993 | CA1314228C Naphthyridine antianaerobic compounds |
03/09/1993 | CA1314227C Pharmaceutical composition containing ketotifen |
03/09/1993 | CA1314226C Anti-dementia agent |
03/09/1993 | CA1314225C Controlled release agent for cetylpyridinium chloride |
03/09/1993 | CA1314224C Antidiabetic agent |
03/09/1993 | CA1314223C Composition for treating gastrointestinal disorders |
03/09/1993 | CA1314222C Pharmaceutical composition for use against hypertension and congestive heart failure |
03/09/1993 | CA1314221C Antiinfective composition containing non-ionic surfactant |
03/09/1993 | CA1314220C Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
03/09/1993 | CA1314219C Use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs |
03/09/1993 | CA1314218C Remote administration of hyaluronic acid to mammals |